| 859.04 -7.34 (-0.85%) | 04-20 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1065.63 |
1-year : | 1113.89 |
| Resists | First : | 912.36 |
Second : | 953.67 |
| Pivot price | 865.95 |
|||
| Supports | First : | 845.52 | Second : | 703.47 |
| MAs | MA(5) : | 863.79 |
MA(20) : | 867.58 |
| MA(100) : | 871.78 |
MA(250) : | 787.35  |
|
| MACD | MACD : | -12.1 |
Signal : | -13.4 |
| %K %D | K(14,3) : | 44.8 |
D(3) : | 44.7 |
| RSI | RSI(14): 39.1 |
|||
| 52-week | High : | 999 | Low : | 635.11 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ MCK ] has closed above bottom band by 25.3%. Bollinger Bands are 67.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 873.41 - 879.28 | 879.28 - 884.14 |
| Low: | 842.16 - 847.89 | 847.89 - 852.64 |
| Close: | 850.65 - 859.95 | 859.95 - 867.66 |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Mon, 20 Apr 2026
Evercore ISI lowers McKesson (MCK) target, adds to tactical underperform list - MSN
Mon, 20 Apr 2026
BofA lowers McKesson (MCK) price target, flags GLP-1 pricing pressure - MSN
Mon, 20 Apr 2026
McKesson to sell minority stake in business unit to Apollo for $1.25 billion - The Business Journals
Mon, 20 Apr 2026
McKesson sells minority stake in surgical supplies unit to Apollo Funds for $1.25 billion - Reuters
Mon, 20 Apr 2026
Evercore ISI keeps McKesson stock Outperform on Apollo stake deal - Investing.com
Mon, 20 Apr 2026
McKesson to Sell Stake of Medical-Surgical Unit to Apollo - WSJ
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 122 (M) |
| Shares Float | 122 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 91.5 (%) |
| Shares Short | 2,500 (K) |
| Shares Short P.Month | 2,060 (K) |
| EPS | 34.65 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -10.56 |
| Profit Margin | 1 % |
| Operating Margin | 1.5 % |
| Return on Assets (ttm) | 4.3 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 11.3 % |
| Gross Profit (p.s.) | 112.17 |
| Sales Per Share | 3248.91 |
| EBITDA (p.s.) | 48.41 |
| Qtrly Earnings Growth | 38 % |
| Operating Cash Flow | 10,480 (M) |
| Levered Free Cash Flow | 9,160 (M) |
| PE Ratio | 24.78 |
| PEG Ratio | 1 |
| Price to Book value | -81.43 |
| Price to Sales | 0.26 |
| Price to Cash Flow | 10.04 |
| Dividend | 0.81 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|